How might shockwaves help fractures heal? A 2023 mini review · Lab study · 2023
How might shockwave help broken bones heal?
This short review gathers dog, rat and cell studies on how shockwave might help a broken bone heal. In dogs with a broken shin bone, the treated leg had more new bone at 12 weeks, though not at 8. In rats and cells, shockwave raised signals that drive bone building. The authors say the exact mechanism is still unclear.
Explores how shockwave works- sources of evidence: dogs, rats and cells grown in the lab
- 3
- weeks before treated dog bones showed more new bone
- 12
- year published
- 2023
Good to know: A short review.
Lv F, Li Z, Jing Y, et al. Front Endocrinol (Lausanne), 2023 · Read the paper ↗
The treatment
- Doses in the cited animal experiments
- Dog tibial fractures: 0.18 mJ/mm², right tibia treated, left tibia untreated. Rat bilateral proximal tibial osteotomy with internal fixation (60 rats): one session at 0.26 mJ/mm², 2,000 pulses at 60 per minute, left side treated, right untreated. Rat femoral defects: 0.16 mJ/mm², 2,500 pulses. Pulse counts, sessions and device type are not given for the dog study.
- Human treatment regimen
- Not reported. The review gives no dose, session schedule, device type or anaesthesia for treating people with fractures.
Who took part
Dogs and rats with broken or cut leg bones, and bone and connective-tissue cells grown in the lab.
Side effects
The review does not report side effects.
All the numbers and the full appraisal
What the full paper reports.
No patient cohort. The cited experiments use dogs (tibial fractures), rats (tibial osteotomy, femoral segmental defects), a tendon-injury model and cultured bone-marrow stromal cells, osteoblasts and fibroblasts. The only clinical outcome figures cited concern heel pain and calcific rotator cuff tendinitis, not fractures, and their reference numbers point to animal studies. The review's statements that shockwaves help nonunion (Abstract, Sections 1 and 4) come with no data.
Proposed physical effects1 reported outcome
Proposed physical effects
Qualitative finding
The review describes stress and shear at tissue interfaces, cavitation with micro-jets, fragmentation of dense tissue (explained from kidney-stone lithotripsy), metabolic activation through VEGF and nitric oxide pathways, and microfractures in old callus with subperiosteal hematoma that may restart healing. It notes that the same stress effects may also damage tissue.
Analysis details and source
Explanatory statements supported by citations to cell, animal and lithotripsy literature; no measurements are presented in the review.
Callus in a dog tibial fracture model1 reported outcome
Callus in a dog tibial fracture model
Qualitative finding
With 0.18 mJ/mm² to the right tibia and the left tibia as control, callus formation did not differ significantly at 8 weeks but was greater in the treated limb at 12 weeks; histology showed a thicker, denser cortex. The review reads this as a time-dependent effect.
Analysis details and source
Animal result; the number of dogs is not given. The review calls the callus "poroma". The reference title describes acute tibial fractures, not nonunion.
Growth factors in rats and cultured cells1 reported outcome
Growth factors in rats and cultured cells
Qualitative finding
BMP-2: the review reports that one 0.26 mJ/mm² session may promote BMP-2 expression at the osteotomy site in 60 rats (an osteoporotic-fracture model by the reference title). TGF-β: significantly higher (P <0.05) 3 days after 0.16 mJ/mm², 2,500 pulses, in rat femoral defects. CBF-α1: ERK-dependent activation and osteoprogenitor differentiation in cell studies. VEGF: higher secretion by osteoblasts after exposure. IGF: rising expression with cell proliferation in a tendon-injury study. FGF: significant rise 24 hours after exposure, correlated with pulse number (p <0.05).
Analysis details and source
Laboratory and animal findings as summarized in the review, without effect sizes. The FGF statement speaks of levels "in the body", but the cited reference title describes cultured human osteoblasts and fibroblasts.
PDGF: no shockwave data cited1 reported outcome
PDGF: no shockwave data cited
Qualitative finding
The PDGF section cites only pulsed ultrasound and other mechanical stimulation, yet the summary states that all seven factors, PDGF included, have been shown to respond to shockwaves.
Analysis details and source
Contradiction between Section 3.7 and Section 4, recorded as found.
Clinical statements outside fractures1 reported outcome
Clinical statements outside fractures
Qualitative finding
To support a time-dependent and cumulative effect, the review cites a prospective heel-pain series (12 weeks: 20.6% complete, 52.90% near-complete and 17.7% partial relief) and a statement that longer treatment worked better in calcific rotator cuff tendinitis.
Analysis details and source
Uncontrolled figures with no denominator. The heel-pain series is cited as reference 23 (a rat femoral-defect study) and the rotator cuff statement as reference 22 (an animal study of normal bone), so neither source can be traced from the review.
How treatment was delivered
Dog tibial fractures: 0.18 mJ/mm², right tibia treated, left tibia untreated. Rat bilateral proximal tibial osteotomy with internal fixation (60 rats): one session at 0.26 mJ/mm², 2,000 pulses at 60 per minute, left side treated, right untreated. Rat femoral defects: 0.16 mJ/mm², 2,500 pulses. Pulse counts, sessions and device type are not given for the dog study.
Not reported. The review gives no dose, session schedule, device type or anaesthesia for treating people with fractures.
No harms data. The review notes that the stress effects of shockwaves may also be a mechanism of tissue damage, and it calls the treatment safe and cost-effective, citing two references (a stroke spasticity review and a periosteal stem-cell study) whose titles do not concern fracture safety or cost.
Author-stated: the biological mechanism of shockwave-promoted nonunion healing is still unclear and there is no consensus on it.
Extractor: mini review with no search, selection criteria or appraisal; the evidence is almost entirely animal and cell work, much of it from one research group, so selective citation cannot be excluded. Doses come from single animal experiments and are not linked to human treatment.
Citation problems: references 22 and 23 do not match the rotator cuff and heel-pain statements; the IGF claim attributed to a mouse model cites a tendinitis study (reference 53); references 23 and 45 are the same paper; reference 17 has a DOI that belongs to another journal; the claims of safety and cost-effectiveness cite references 6–7, whose titles concern stroke spasticity and periosteal stem cells.
Extractor: the opening sentence that clinical efficacy in nonunion is widely recognized rests on three references that the review does not appraise; it should not be read as a measured benefit. Funding: First Hospital of Jilin University fund (No. JDYYZH-2022012). Conflicts: none declared.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Author-stated: the biological mechanism of shockwave-promoted nonunion healing is still unclear and there is no consensus on it.
- Extractor: mini review with no search, selection criteria or appraisal; the evidence is almost entirely animal and cell work, much of it from one research group, so selective citation cannot be excluded. Doses come from single animal experiments and are not linked to human treatment.
- Citation problems: references 22 and 23 do not match the rotator cuff and heel-pain statements; the IGF claim attributed to a mouse model cites a tendinitis study (reference 53); references 23 and 45 are the same paper; reference 17 has a DOI that belongs to another journal; the claims of safety and cost-effectiveness cite references 6–7, whose titles concern stroke spasticity and periosteal stem cells.
- Extractor: the opening sentence that clinical efficacy in nonunion is widely recognized rests on three references that the review does not appraise; it should not be read as a measured benefit. Funding: First Hospital of Jilin University fund (No. JDYYZH-2022012). Conflicts: none declared.
Source-linked critical reading
Narrative mini review
Technical source record
Complete local PDF read (7 pages), including all sections, funding, conflict statement and the full reference list. The article has no tables or figures. Cited primary studies were not read.
In animals and cell cultures, shockwaves have been linked to more callus and to higher levels of bone-building and blood-vessel signals. This mini review gathers those laboratory findings; it does not show whether, or how well, treatment helps fractures heal in people, and the authors say the mechanism remains unclear.
Which physical effects of shockwaves and which bone growth factors might explain how shockwave therapy helps delayed or failed fracture healing?
Narrative mini review. It describes physical effects of shockwaves (stress gradients, cavitation, fragmentation of dense tissue, metabolic activation, osteogenesis) and seven growth factors (BMP, TGF-β, CBF-α1, VEGF, IGF, FGF, PDGF). There is no search strategy, selection criteria, quality appraisal or new data, and almost every experiment cited is in animals or cell cultures.
No patient cohort. The cited experiments use dogs (tibial fractures), rats (tibial osteotomy, femoral segmental defects), a tendon-injury model and cultured bone-marrow stromal cells, osteoblasts and fibroblasts. The only clinical outcome figures cited concern heel pain and calcific rotator cuff tendinitis, not fractures, and their reference numbers point to animal studies. The review's statements that shockwaves help nonunion (Abstract, Sections 1 and 4) come with no data.
Doses are given only for single experiments: dog tibial fractures at 0.18 mJ/mm²; rat tibial osteotomy at 0.26 mJ/mm², 2,000 pulses at 60 per minute, one session ("roughly focused"); rat femoral defects at 0.16 mJ/mm², 2,500 pulses. Device type is not stated for most experiments, and no treatment regimen for people with fractures is described.
In the animal experiments the comparison is usually the untreated opposite limb (dog and rat tibia) or untreated tissue. The review makes no comparison of its own and describes no comparative study of people with fractures.
Callus on imaging and histology in dogs, growth-factor expression (BMP-2, TGF-β1, VEGF, IGF-1, FGF) and osteoblast differentiation signals (ERK and CBF-α1) in animals and cultured cells, at time points from 24 hours to 12 weeks. No clinical outcome such as union rate, pain or function is analysed.
Dogs treated at 0.18 mJ/mm² showed no callus difference at 8 weeks but more callus and a thicker cortex at 12 weeks. In rats, the review reports that one session at 0.26 mJ/mm² may promote BMP-2 expression (an osteoporotic-fracture model by the reference title), and that 0.16 mJ/mm² raised TGF-β within 3 days (P <0.05). Cell studies link shockwaves to ERK-dependent CBF-α1 activation, VEGF release and an FGF rise at 24 hours. For PDGF only pulsed-ultrasound evidence is cited, although the summary lists PDGF among the factors shown. The authors state that the mechanism is still unclear and that there is no consensus on it.
No harms data. The review notes that the stress effects of shockwaves may also be a mechanism of tissue damage, and it calls the treatment safe and cost-effective, citing two references (a stroke spasticity review and a periosteal stem-cell study) whose titles do not concern fracture safety or cost.
Mini review without search methods or appraisal; the evidence is almost entirely animal and cell work, much of it from one research group, at doses rarely comparable to clinical use. Several citations do not match the statements: the rotator cuff and heel-pain claims cite an animal bone study and a rat femoral-defect study; an IGF claim attributed to a mouse model cites a tendinitis study; one reference appears twice (23 and 45); reference 17 carries a DOI from another journal. The opening claim that clinical efficacy in nonunion is widely recognized is not examined. Funding: a First Hospital of Jilin University fund; no conflicts declared.
Background for understanding the biological hypotheses behind shockwave use in delayed union and nonunion. It cannot show whether, or how often, treatment helps a person's fracture heal, and its animal doses are not a treatment regimen.
Human studies that measure these biological signals at the fracture site alongside blinded radiographic union, and comparative trials against standard care with doses reported in comparable units.
Read the original article.
The effects and underlying mechanism of extracorporeal shockwave therapy on fracture healing.
Lv F, Li Z, Jing Y, Sun L, Li Z, Duan H. · Front Endocrinol (Lausanne) · 2023
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →